CVE vs VET

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

CVE

47.1
AI Score
VS
CVE Wins

VET

37.7
AI Score

Investment Advisor Scores

CVE

47score
Recommendation
HOLD

VET

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric CVE VET Winner
Forward P/E 9.7182 25.7732 CVE
PEG Ratio 0.45 3.58 CVE
Revenue Growth 41.5% 23.1% CVE
Earnings Growth 239.1% -94.9% CVE
Tradestie Score 47.1/100 37.7/100 CVE
Profit Margin 12.4% -24.2% CVE
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL CVE

Relative Price Performance (Last 90 Days)

CVE 1M: +10.8% · 3M: +8.7% VET 1M: +13.3% · 3M: +3.5%

Current Technical Phase

CVE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.0% over 20 days), RSI 72

RSI (14): 72.2 · Price: $32.93

VET

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 68.2 · Price: $12.73

Fundamentals Snapshot

Metric CVE VET
Market Cap
Forward P/E 12.6 11.8
Trailing P/E 12.5
Revenue (TTM)
Revenue Growth 0.4% 0.2%
Gross Margin 0.3% 0.6%
Operating Margin 0.2% 0.5%
EPS 2.60 -2.15
Dividend Yield 0.03% 0.04%

Frequently Asked Questions

Based on our detailed analysis, CVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.